PIPages
Labs

Donita C Brady

University of Pennsylvania, PA·Biochemistry

Cancer cells and healthy cells depend on more than their genes. What a cell actually does is set by its proteins and by the small molecules and metals that switch those proteins on and off.

Fields

Biochemistry

Chemistry

Pharmacology

Topics

chemical biology

chemical probes

proteomics

Grants
2 known grants, through Aug 2027

What they work on

  1. Develop Probe Enabled Activity Reporting (PEAR), using chemical biology probes that tag reactive proteins, to visualize and identify protein targets in patient-derived cancer models.
  2. Identify protein targets whose probe reactivity changes after cancer treatment, and establish their functional roles in how tumor cells adapt to therapy.
  3. Establish a method that profiles probe-reactive proteins in separate compartments of the cell, to uncover distinct features of tumor cell biology.
  4. Determine how copper controls autophagy, the cell's recycling process, and the formation and function of lysosomes, its recycling compartments.
  5. Determine how copper directly controls glycolytic flux, the rate of sugar breakdown, so cells can adapt metabolically under nutrient and oxygen stress.
  6. Define how copper transport into mitochondria connects to nutrient-sensing signaling pathways in the cytosol that are needed for metabolism.

More about the research

Two projects study this protein-level control. One builds chemical tools that read changing protein activity inside tumors and track how it shifts with therapy. The other asks how copper, a metal we get from our diet, acts as a signal that tunes cell growth, nutrient recycling and metabolism.

Why it matters

Genetic tests alone often fail to predict how a tumor will respond to treatment. Tools that read protein activity directly could reveal hidden weak points in solid tumors, predict therapeutic responses and guide new targeted drugs and diagnostics. Understanding how copper controls signaling and energy balance could point to treatments that exploit copper-dependent vulnerabilities in disease.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Unlocking the Chemical Space of Cancer-Associated Perturbations

NIH · Sep 2022 – Aug 2027

Molecular and Cellular Mechanisms of Copper-Dependent Nutrient Signaling and Metabolism

NIH · Aug 2017 – Jul 2027

Closest labs

Qingfei Zheng

Purdue University, IN·Biochemistry

Develop chemical probes that selectively label and enrich different histone monoaminylations, such as serotonylation and dopaminylation of histone H3 at glutamine 5 (H3Q5).

Amy Barrios

University of Utah, UT·Biochemistry

Develop fluorogenic peptide substrates, molecules that fluoresce when cut by an enzyme, that are selective for LAR receptor tyrosine phosphatases, using sequences of their known biological targets, and validate them for use in cells.

Brittany Allen-Petersen

Purdue University, IN·Biochemistry

Identify how PP2A-B56α, a subunit of a phosphate-removing enzyme, controls the fusion of macropinosomes with lysosomes, focusing on chemical changes made to proteins after they are built.

The school

University of Pennsylvania: 90 labs on PI Pages, $2.2B a year on research, 750 research doctorates a year.

More about University of Pennsylvania

Reach out

A start for your email. Fill in the brackets.